Novanta is a scientific & technical instruments business based in the US. Novanta shares (NOVT) are listed on the NASDAQ and all prices are listed in US Dollars. Novanta employs 3,000 staff and has a trailing 12-month revenue of around $960.3 million.
Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Trade stocks, ETFs, options, futures and bonds all in one place
$0 commissions on stocks, ETFs and equity options, with low contract fees
Deposit or transfer $10,000+ to earn a 2% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&C apply.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Novanta stock price (NASDAQ: NOVT)
Use our graph to track the performance of NOVT stocks over time.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Novanta stock undervalued or overvalued?
Valuing Novanta stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Novanta's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Novanta's P/E ratio
Novanta's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 77x. In other words, Novanta shares trade at around 77x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Novanta's PEG ratio
Novanta's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.11. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Novanta's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Novanta's EBITDA
Novanta's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $180.5 million.
The EBITDA is a measure of a Novanta's overall financial performance and is widely used to measure a its profitability.
Novanta financials
Revenue TTM
$960.3 million
Operating margin TTM
11.51%
Gross profit TTM
$433 million
Return on assets TTM
5.18%
Return on equity TTM
6.84%
Profit margin
5.5%
Book value
$22.36
Market Capitalization
$4 billion
TTM: trailing 12 months
Novanta share dividends
We're not expecting Novanta to pay a dividend over the next 12 months.
Have Novanta's shares ever split?
Novanta's shares were
split on a 1:3 basis on 28 December 2010
. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Novanta shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Novanta shares which in turn could have impacted Novanta's share price.
Novanta share price volatility
Over the last 12 months, Novanta's shares have ranged in value from as little as $98.27 up to $173.16. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Novanta's is 1.587. This would suggest that Novanta's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Novanta overview
Novanta Inc. , together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; laser beam delivery solutions; video processing, streaming, and capture; machine vision technologies; radio frequency identification (RFID) technologies; barcode identification technologies; thermal chart recorders; light and color measurement technologies; touch panel displays; and advanced motion control solutions. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands.
Frequently asked questions
What percentage of Novanta is owned by insiders or institutions? Currently 0.981% of Novanta shares are held by insiders and 103.136% by institutions.How many people work for Novanta? Latest data suggests 3,000 work at Novanta.When does the fiscal year end for Novanta? Novanta's fiscal year ends in December.Where is Novanta based? Novanta's address is: 125 Middlesex Turnpike, Bedford, MA, United States, 01730What is Novanta's ISIN number? Novanta's international securities identification number is: US67000B1044What is Novanta's CUSIP number? Novanta's Committee on Uniform Securities Identification Procedures number is: 36191C106
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
